{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T14:44:27Z","timestamp":1782398667710,"version":"3.54.5"},"reference-count":39,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,5,19]],"date-time":"2017-05-19T00:00:00Z","timestamp":1495152000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaci-inpractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jaip.2017.04.010","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T22:30:32Z","timestamp":1496874632000},"page":"1671-1678.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema"],"prefix":"10.1016","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3610-9852","authenticated-orcid":false,"given":"Henriette","family":"Farkas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4378-0329","authenticated-orcid":false,"given":"Avner","family":"Reshef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Aberer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3005-9858","authenticated-orcid":false,"given":"Teresa","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfram","family":"Nothaft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Schranz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Henry","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaip.2017.04.010_bib1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.04.010_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.iac.2006.08.004","article-title":"Structure and function of C1-inhibitor","volume":"26","author":"Wagenaar-Bos","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaip.2017.04.010_bib3","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0171-2985(98)80040-5","article-title":"Molecular genetics of C1 inhibitor","volume":"199","author":"Tosi","year":"1998","journal-title":"Immunobiology"},{"key":"10.1016\/j.jaip.2017.04.010_bib4","first-page":"S25","article-title":"The pathophysiology of hereditary angioedema","volume":"3","author":"Zuraw","year":"2010","journal-title":"World Allergy Organization J"},{"key":"10.1016\/j.jaip.2017.04.010_bib5","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.87.1.265","article-title":"Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene","volume":"87","author":"Levy","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaip.2017.04.010_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1710-1492-6-19","article-title":"Management of upper airway edema caused by hereditary angio-edema","volume":"6","author":"Farkas","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.010_bib7","first-page":"151","article-title":"An update on the diagnosis and management of hereditary angioedema with abnormal c1 inhibitor","volume":"14","author":"Davis-Lorton","year":"2015","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.jaip.2017.04.010_bib8","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.aller.2012.01.002","article-title":"Angio-oedema due to hereditary C1 inhibitor deficiency in children","volume":"41","author":"Caballero","year":"2013","journal-title":"Allergologia et Immunopathologia"},{"key":"10.1016\/j.jaip.2017.04.010_bib9","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2500\/aap.2015.36.3824","article-title":"Current state of hereditary angioedema management: a patient survey","volume":"36","author":"Banerji","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2017.04.010_bib10","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.amjmed.2005.09.064","article-title":"Hereditary angioedema: new findings concerning symptoms, affected organs, and course","volume":"119","author":"Bork","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.jaip.2017.04.010_bib11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jaip.2014.11.012","article-title":"Clinical features of pediatric hereditary angioedema","volume":"3","author":"Nanda","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.04.010_bib12","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jpeds.2012.11.030","article-title":"Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children","volume":"162","author":"Lumry","year":"2013","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jaip.2017.04.010_bib13","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.anai.2012.10.008","article-title":"International consensus on hereditary and acquired angioedema","volume":"109","author":"Lang","year":"2012","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.010_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2500\/aap.2010.31.3394","article-title":"The humanistic burden of hereditary angioedema: impact on health-related quality of life, productivity, and depression","volume":"31","author":"Lumry","year":"2010","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.jaip.2017.04.010_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1177\/0009922815616886","article-title":"Pediatric hereditary angioedema: onset, diagnostic delay, and disease severity","volume":"55","author":"Christiansen","year":"2016","journal-title":"Clin Pediatr"},{"key":"10.1016\/j.jaip.2017.04.010_bib16","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1097\/WOX.0b013e318279affa","article-title":"WAO guideline for the management of hereditary angioedema","volume":"5","author":"Craig","year":"2012","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaip.2017.04.010_bib17","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00431-012-1726-4","article-title":"Hereditary angioedema (HAE) in children and adolescents\u2014a consensus on therapeutic strategies","volume":"171","author":"Wahn","year":"2012","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaip.2017.04.010_bib18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1398-9995.2011.02751.x","article-title":"Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group","volume":"67","author":"Cicardi","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.04.010_bib19","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.jaip.2013.07.002","article-title":"US Hereditary Angioedema Association Medical Advisory Board 2013 recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency","volume":"1","author":"Zuraw","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaip.2017.04.010_bib20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1710-1492-6-24","article-title":"2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema","volume":"6","author":"Bowen","year":"2010","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.010_bib21","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/all.13001","article-title":"International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1-inhibitor deficiency","volume":"72","author":"Farkas","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.04.010_bib22","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1056\/NEJMoa0906393","article-title":"Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema","volume":"363","author":"Cicardi","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jaip.2017.04.010_bib23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.anai.2011.08.015","article-title":"Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial","volume":"107","author":"Lumry","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaip.2017.04.010_bib24","series-title":"Firazyr [package insert]","year":"2015"},{"key":"10.1016\/j.jaip.2017.04.010_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0304-3959(90)90018-9","article-title":"The Faces Pain Scale for the self-assessment of the severity of pain experienced by children: development, initial validation, and preliminary investigation for ratio scale properties","volume":"41","author":"Bieri","year":"1990","journal-title":"Pain"},{"key":"10.1016\/j.jaip.2017.04.010_bib26","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3959(01)00314-1","article-title":"The Faces Pain Scale-Revised: toward a common metric in pediatric pain measurement","volume":"93","author":"Hicks","year":"2001","journal-title":"Pain"},{"key":"10.1016\/j.jaip.2017.04.010_bib27","unstructured":"Covance. Bioanalytical sample analysis report: quantitative determination of icatibant, icatibant M-1 and icatibant M-2 in human plasma samples by UPLC M\/MS for protocol HGT-FIR-086. 2016. Shire data on file."},{"key":"10.1016\/j.jaip.2017.04.010_bib28","first-page":"293","article-title":"The FLACC: a behavioral scale for scoring postoperative pain in young children","volume":"23","author":"Merkel","year":"1997","journal-title":"Pediatr Nurs"},{"key":"10.1016\/j.jaip.2017.04.010_bib29","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/cpdd.138","article-title":"Pharmacokinetics of single and repeat doses of icatibant","volume":"4","author":"Leach","year":"2015","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.jaip.2017.04.010_bib30","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/pai.12024","article-title":"C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies","volume":"24","author":"Schneider","year":"2013","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2017.04.010_bib31","first-page":"294","article-title":"Pediatric use of a C1 esterase inhibitor concentrate as on demand treatment or short-term prophylaxis of hereditary angioedema: findings from a large international registry","volume":"70","author":"Martinez-Saguer","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.jaip.2017.04.010_bib32","doi-asserted-by":"crossref","first-page":"AB193","DOI":"10.1016\/j.jaci.2014.12.1567","article-title":"Hereditary angioedema: clinical characteristics and treatment response with Berinert in a French cohort in patient under 16 years old","volume":"135","author":"Boccon-Gibod","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.010_bib33","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/pai.12444","article-title":"Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema","volume":"26","author":"Lumry","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaip.2017.04.010_bib34","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jaci.2012.08.036","article-title":"Treatment of attacks with plasma-derived C1-inhibitor concentrate in pediatric hereditary angioedema patients","volume":"131","author":"Farkas","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.jaip.2017.04.010_bib35","series-title":"Ruconest [package insert]","year":"2015"},{"key":"10.1016\/j.jaip.2017.04.010_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2217\/imt.15.44","article-title":"Recombinant replacement therapy for hereditary angioedema due to C1 inhibitor deficiency","volume":"7","author":"Moldovan","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jaip.2017.04.010_bib37","doi-asserted-by":"crossref","first-page":"e490","DOI":"10.1542\/peds.2013-0646","article-title":"Use of ecallantide in pediatric hereditary angioedema","volume":"132","author":"MacGinnitie","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaip.2017.04.010_bib38","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.acthis.2010.03.008","article-title":"Changes in bradykinin and bradykinin B(2)-receptor during estrous cycle of mouse","volume":"113","author":"Singh","year":"2011","journal-title":"Acta Histochemica"},{"key":"10.1016\/j.jaip.2017.04.010_bib39","unstructured":"Meeting P-ADAC. NDA 022-150: Firazyr (icatibant) injection for the treatment of acute attacks of hereditary angioedema (HAE) in patients 18 years of age and older. 2011. Available from: https:\/\/www.fda.gov\/downloads\/...\/CommitteesMeetingMaterials\/Drugs\/...\/UCM260020..... Accessed May 8, 2017."}],"container-title":["The Journal of Allergy and Clinical Immunology: In Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817302532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213219817302532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:13:18Z","timestamp":1761973998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213219817302532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":39,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2213219817302532"],"URL":"https:\/\/doi.org\/10.1016\/j.jaip.2017.04.010","relation":{},"ISSN":["2213-2198"],"issn-type":[{"value":"2213-2198","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema","name":"articletitle","label":"Article Title"},{"value":"The Journal of Allergy and Clinical Immunology: In Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaip.2017.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}